Prolupin Overview

  • Founded
  • 2009
  • Status
  • Private
  • Employees
  • 22
  • Latest Deal Type
  • Series E
  • Latest Deal Amount
  • $25.6M
Latest Deal Amount
  • Investors
  • 14

Prolupin General Information


Producer of lupine-based products intended to extract food ingredients from lupine seeds. The company specializes in the production of herbal food ingredient products that offer cholesterol and lactose-free edibles such as ice cream, milk, pudding, yogurt, and cottage cheese, thereby enabling consumers to get vegan and gluten-free food options.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Food Products
Primary Office
  • Tribseeser Chaussee 1
  • 18507 Grimmen
  • Germany
+49 038326 00000

Prolupin Timeline

Financing RoundFinancing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Prolupin Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC (Series E) 01-Oct-2020 $25.6M 000.00 0000 Completed Generating Revenue
5. Later Stage VC 07-Feb-2018 Completed Generating Revenue
4. Later Stage VC 01-May-2016 Completed Generating Revenue
3. Grant 01-Jan-2014 00000 Completed Startup
2. Early Stage VC 07-Feb-2011 Completed Startup
1. Seed Round 01-Oct-2010 Completed Startup
To view Prolupin’s complete valuation and funding history, request access »

Prolupin Cap Table

Stock # of Shares
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Preference 0,000,000 00.00 00.00 00 00.00 00.000
To view Prolupin’s complete cap table history, request access »

Prolupin Executive Team (5)

Name Title Board Seat Contact Info
Paul Denayer Chief Executive Officer
Christian Fankhänel Chief Financial Officer
Reiner Kuester Chairman of Supervisory Board
You’re viewing 3 of 5 executive team members. Get the full list »

Prolupin Board Members (4)

Name Representing Role Since
David Atkinson Tate & Lyle Ventures Board Member 000 0000
Michael Sailer Self Board Member 000 0000
Reiner Kuester Prolupin Chairman of Supervisory Board 000 0000
You’re viewing 3 of 4 board members. Get the full list »

Prolupin Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Prolupin Investors (14)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Capricorn Partners Venture Capital Minority 000 0000 000000 0
ECBF Management Venture Capital Minority 000 0000 000000 0
Novax Growth/Expansion Minority 000 0000 000000 0
Quest For Growth Asset Manager Minority 000 0000 000000 0
SevenVentures Corporate Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 14 investors. Get the full list »